Current：Home > MyNew drugs. Cheaper drugs. Why not both? -TradeWisdom
New drugs. Cheaper drugs. Why not both?
Indexbit Exchange View
Date：2025-04-08 10:09:42
Here's the argument: Americans pay loads for drugs. That motivates and funds pharmaceutical companies' research and development for better drugs. The fear is that if you lower the cost of drugs you might hurt overall innovation.
Today on the show, we speak with a health economist who argues that's not always true. In fact, she says there are a bunch of policies that could help bring down drug prices without stifling innovation.
Music by Drop Electric. Find us: Twitter / Facebook / Newsletter.
Subscribe to our show on Apple Podcasts, Spotify, Pocket Casts and NPR One.
For sponsor-free episodes of The Indicator from Planet Money, subscribe to Planet Money+ via Apple Podcasts or at plus.npr.org.
veryGood！ (85)
Related
- Hackers hit Rhode Island benefits system in major cyberattack. Personal data could be released soon
- Alabama Barker Praises “Hot Mama” Kourtney Kardashian’s Latest Pregnancy Pics
- Candidate in high-stakes Virginia election performed sex acts with husband in live videos
- Aaron Rodgers: QB’s shocking injury latest in line of unforgettable Jets debuts
- Realtor group picks top 10 housing hot spots for 2025: Did your city make the list?
- Armenia launches joint military drills with United States that anger Moscow
- Spectrum TV users get ESPN, Disney channels back ahead of 'Monday Night Football' debut
- In flood-stricken central Greece, residents face acute water shortages and a public health warning
- Highlights from Trump’s interview with Time magazine
- US already struck by record number of billion-dollar disasters in 2023: NOAA
Ranking
- The Grammy nominee you need to hear: Esperanza Spalding
- Judges refuse to pause order for Alabama to draw new congressional districts while state appeals
- McCarthy juggles government shutdown and potential Biden impeachment inquiry as House returns
- Tip for misogynistic men: Stop thinking you're entitled to what you aren't
- Mets have visions of grandeur, and a dynasty, with Juan Soto as major catalyst
- A decision in Texas AG’s Ken Paxton’s impeachment trial could happen as soon as this week
- Starbucks gave trans employees a lifeline. Then they put our health care at risk.
- Court convicts Portuguese hacker in Football Leaks trial and gives him a 4-year suspended sentence
Recommendation
Justice Department, Louisville reach deal after probe prompted by Breonna Taylor killing
Michigan State University football coach Mel Tucker denies sexually harassing Brenda Tracy
DraftKings receives backlash for 'Never Forget' 9/11 parlay on New York teams
'We weren't quitting': How 81-year-old cancer survivor conquered Grand Canyon's rim-to-rim hike
North Carolina trustees approve Bill Belichick’s deal ahead of introductory news conference
US approves updated COVID vaccines to rev up protection this fall
The New York ethics commission that pursued former Governor Cuomo is unconstitutional, a judge says
Analysis: Novak Djokovic isn’t surprised he keeps winning Grand Slam titles. We shouldn’t be, either